Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones

Journal of Peptide Science

Volumn 7, Issue 1, 2001, Pages 27-40

  Marchetto, Reinaldo ^a,b   Nicolás, Ernesto ^a   Castillo, Núria ^a   Bacardit, Jordi ^a   Navia, Margarita ^a   Vila, Jordi ^a   Giralt, Ernest ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Affinity chromatography; DNA gyrase; Escherichia coli; Peptide design; Peptide synthesis; Quinolones; Solid phase; Topoisomerases

Indexed keywords

ASPARAGINE; ASPARTIC ACID; BACTERIAL DNA; BACTERIAL ENZYME; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); LEUCINE; MAGNESIUM ION; QUINOLONE DERIVATIVE; SERINE; SYNTHETIC PEPTIDE; TYROSINE;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CATALYSIS; DNA REPLICATION; DNA TRANSCRIPTION; DRUG BINDING; DRUG DESIGN; DRUG MECHANISM; DRUG RESISTANCE; DRUG SYNTHESIS; ENZYME SUBUNIT; ESCHERICHIA COLI; GENE MUTATION; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BINDING SITES; CHROMATOGRAPHY, AFFINITY; CIPROFLOXACIN; DNA TOPOISOMERASES, TYPE II; DRUG DESIGN; ESCHERICHIA COLI; MOLECULAR PROBES; MUTATION; PEPTIDES; SPECTROMETRY, FLUORESCENCE;

ESCHERICHIA COLI;

EID: 0035109610     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.292     Document Type: Article

References (41)

1. DNA gyrase: An enzyme that introduces superhelical turns into DNA
2. DNA gyrase: Structure and function
3. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: A co-operative drug-DNA binding model
4. On the mechanism of action of quinolone drugs
5. Mutational analysis of a type II topoisomerase cleavage site: Distinct requirements for enzyme and inhibitors
6. 2+ complex on DNA: A new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex
7. Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex
8. A single point mutation in the DNA gyrase A protein greatly reduced binding of fluoroquinolones to the gyrase-DNA complex
9. Mechanism of action of quinolones against Escherichia coli DNA gyrase
10. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: Effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth
11. DNA topoisomerase poisons as antitumor drugs
12. The molecular basis of quinolone action
13. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase
14. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex
15. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex
16. Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV
17. Mapping the active site tyrosine of Escherichia coli DNA gyrase
18. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs
19. 2+, DNA and DNA gyrase, studied by phase partitioning in an aqueous two-phase system and by affinity chromatography
20. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: Specificity and cooperativity of drug binding to DNA
21. A rapid alkaline extraction procedure for screening recombinant plasmid DNA
22. Solid-phase peptide synthesis
23. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
24. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: The target of the drugs is DNA
25. Protein interactions with small molecules
26. Probing the limits of the DNA breakage-reunion domain of the Escherichia coli DNA gyrase A protein
27. Crystal structure of the breakage-reunion domain of DNA gyrase
28. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis
29. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus
30. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance
31. The orientation of norfloxacin bound to double-stranded DNA
32. Quinolone binding to DNA is mediated by magnesium ions
33. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments
34. The binding of gyrase to DNA: Analysis by retention by nitrocellulose filters
35. The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage
36. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes
37. The interaction of daunorubicin and doxorubicin with DNA and chromatin